ADVFN ADVFN
市場データ
ニュース
投資ツール
市場
発見

Hot Features

Follow Feed

フォローフィードコミュニティでトレーダーや投資家とつながりましょう.

ライブオプションフロー

包括的なオプション データを調査し、オプション フローで高度なフィルターを使用します.

モニター

ターミナル モニターで株式と資産のウォッチリストを整理および監視します
Premium Iconプレミアム Help Menu
Bitcoin
62,081.28
-0.17%
S&P 500
7,266.99
-1.62%
Dow Jones
49,918.78
-1.87%
US Dollar vs Yen
160.4665
-0.04%
Brent Oil
93.215
-0.30%
Icon for discussion 登録して、同じ考えを持つ投資家と議論するためのアクティブなフォーラムで相互作用するためのアクティブなフォーラムに参加してください。
  1. ホーム
  2. 投資
  3. 株式
  4. アメリカ
  5. USOTC

  6. Poniard Pharmaceuticals Inc (EM) (PARD) 銘柄情報

Poniard Pharmaceuticals Inc (EM)

Poniard Pharmaceuticals Inc (EM) (PARD)

USOTC
0.0001
0.00
(0.00%)
終了 6月11日 5:00AM

Poniard Pharmaceuticals Inc (EM) (PARD) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

主要統計と詳細

通貨
0.0001
( - )
買値
0.00
売値
0.00
出来高
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.0001
時価総額
149.916
前日終値
0.0001
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
US$ 110
発行済株式数
1,499,159
配当利回り
PER
-0
1 株当たり利益 (EPS)
-3.79
歳入
-
純利益
-16.04M

Poniard Pharmaceuticals Inc (EM) について

Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, p... Poniard Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of cancer therapeutics. Its lead platform product candidate includes Picoplatin, a platinum-based cancer therapy to treat multiple cancer indications, including small cell lung, colorectal, prostate, and ovarian cancers. The company has conducted a pivotal Phase III SPEAR trial of Picoplatin in the second-line treatment of patients with small cell lung cancer; Phase II trials evaluating picoplatin as a first-line treatment of metastatic colorectal cancer and castration-resistant prostate cancer; and a Phase I study evaluating an oral formulation of picoplatin in solid tumors. The company was formerly known as NeoRx Corporation and changed its name to Poniard Pharmaceuticals, Inc. in September 2006. Poniard Pharmaceuticals, Inc. was founded in 1984 and is based in Seattle, Washington. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
本社
Seattle, United States
設立
1984
Poniard Pharmaceuticals Inc (EM) is listed in the Healthcare sector of the その他OTC with ticker PARD. The last closing price for Poniard Pharmaceuticals (EM) was US$0. Over the last year, Poniard Pharmaceuticals (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0001.

Poniard Pharmaceuticals (EM) currently has 1,499,159 shares in issue. The market capitalisation of Poniard Pharmaceuticals (EM) is US$149.92 . Poniard Pharmaceuticals (EM) has a price to earnings ratio (PE ratio) of -0.00.

PARD 最新ニュース

その他のニュース
期間 †前日比前日比 %始値高値安値平均出来高VWAP
1000.00010.00010.00011210.0001CS
4000.00010.00010.00011200.0001CS
129.0E-59001.0E-50.00011.0E-5577.353E-5CS
26000.00010.00011.0E-5538.462E-5CS
52000.00010.00011.0E-65659.785E-5CS
1569.9E-599001.0E-60.0001011.0E-619556.79E-5CS
260-0.035-99.71509971510.03510.0691.0E-636230.01938716CS

PARD - Frequently Asked Questions (FAQ)

What is the current Poniard Pharmaceuticals Inc (EM) share price?
The current share price of Poniard Pharmaceuticals Inc (EM) is US$ 0.0001
How many Poniard Pharmaceuticals Inc (EM) shares are in issue?
Poniard Pharmaceuticals Inc (EM) has 1,499,159 shares in issue
What is the market cap of Poniard Pharmaceuticals Inc (EM)?
The market capitalisation of Poniard Pharmaceuticals Inc (EM) is USD 149.92
What is the 1 year trading range for Poniard Pharmaceuticals Inc (EM) share price?
Poniard Pharmaceuticals Inc (EM) has traded in the range of US$ 0.000001 to US$ 0.0001 during the past year
What is the PE ratio of Poniard Pharmaceuticals Inc (EM)?
The price to earnings ratio of Poniard Pharmaceuticals Inc (EM) is -0
What is the registered address of Poniard Pharmaceuticals Inc (EM)?
The registered address for Poniard Pharmaceuticals Inc (EM) is 300 Elliott Avenue West, Seattle, Washington, 98119
Which industry sector does Poniard Pharmaceuticals Inc (EM) operate in?
Poniard Pharmaceuticals Inc (EM) operates in the Biotechnology & Life Sciences sector

PARD 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

議論

フィード全体を表示

最近閲覧した銘柄

USOTC
PARD
Poniard Pharmaceuticals (EM)
LSE
IEWQ
Invesco Markets II
TSX
TMD
Titan Medical
USOTC
TKHIF
Takara (PK)
EU
BQAAF
REGBREO Bond 22 Jan 29
EU
AM
Dassault Aviation
NASDAQ
ASLE
AerSale
NASDAQ
YAAS
Youxin Technology
LSE
ASAI
ASA
NASDAQ
PBYI
Puma Biotechnology
USOTC
FDCHF
Funding Circle (PK)
TG
EXSB
BlackRock Asset Manageme...
LSE
IX24
Morg.st.b.v 24
CSE
WMC
Westmount Minerals
ASX
PRN
Perenti
LSE
19WN
Callable Zero Coupon Not...
Delayed Upgrade Clock
ADVFN
日本
会社情報
ビジネス
人気
アプリを入手
App Store
Google Play

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

© 2026 ADVFN Ltd - 全著作権所有

広告を削除する

サインアップして広告なしのエクスペリエンスを体験してください

広告なし

今すぐ試してください

広告を残す